Abstract
Nanotechnology provides researchers with new tools for cancer treatment. Biodegradable polymeric nanoparticles, as an advanced drug delivery system, have promising applications in cancer treatment. Poly(- caprolactone)/poly(ethylene glycol) (PCL/PEG) copolymers are biodegradable and amphiphilic, and show potential application in drug delivery. In recent years, PCL/PEG copolymeric nanoparticles, as a potential nanoplatform for anticancer agent delivery, received increasing attention. This paper reviews PCL/PEG copolymer nanoparticles for anticancer agent delivery, including overcoming water insolubility of hydrophobic drug, targeting chemotherapeutic drug to tumor, and delivering genes, vaccines, and diagnostic agents.
Keywords: Biodegradable polymer, cancer, diagnostic agent, drug delivery system, gene delivery, nanoparticle, poly(-caprolactone)/poly(ethylene glycol) (PCL/PEG) copolymers, vaccine, nano-precipitation method, chemotherapy
Current Drug Targets
Title: PCL/PEG Copolymeric Nanoparticles: Potential Nanoplatforms for Anticancer Agent Delivery
Volume: 12 Issue: 8
Author(s): MaLing Gou, XiaWei Wei, Ke Men, BiLan Wang, Feng Luo, Xia Zhao, YuQuan Wei and ZhiYong Qian
Affiliation:
Keywords: Biodegradable polymer, cancer, diagnostic agent, drug delivery system, gene delivery, nanoparticle, poly(-caprolactone)/poly(ethylene glycol) (PCL/PEG) copolymers, vaccine, nano-precipitation method, chemotherapy
Abstract: Nanotechnology provides researchers with new tools for cancer treatment. Biodegradable polymeric nanoparticles, as an advanced drug delivery system, have promising applications in cancer treatment. Poly(- caprolactone)/poly(ethylene glycol) (PCL/PEG) copolymers are biodegradable and amphiphilic, and show potential application in drug delivery. In recent years, PCL/PEG copolymeric nanoparticles, as a potential nanoplatform for anticancer agent delivery, received increasing attention. This paper reviews PCL/PEG copolymer nanoparticles for anticancer agent delivery, including overcoming water insolubility of hydrophobic drug, targeting chemotherapeutic drug to tumor, and delivering genes, vaccines, and diagnostic agents.
Export Options
About this article
Cite this article as:
Gou MaLing, Wei XiaWei, Men Ke, Wang BiLan, Luo Feng, Zhao Xia, Wei YuQuan and Qian ZhiYong, PCL/PEG Copolymeric Nanoparticles: Potential Nanoplatforms for Anticancer Agent Delivery, Current Drug Targets 2011; 12 (8) . https://dx.doi.org/10.2174/138945011795906642
DOI https://dx.doi.org/10.2174/138945011795906642 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pluripotency and Targeted Reprogramming: Strategies, Disease Modeling and Drug Screening
Current Drug Delivery The Impact of Combination Therapy with a-Blockers and 5ARIs on the Progression of BPH
Current Drug Targets Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders-Drug Targets Curbing the Deregulation of Glycosylation in Tongue Carcinoma Cells with Natural Compounds
Anti-Cancer Agents in Medicinal Chemistry Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Challenges and Solutions in Proteomics
Current Genomics Snake Venom Disintegrins: An Overview of their Interaction with Integrins
Current Drug Targets Observations of the Mechanisms of Electromediated DNA Uptake - From Vesicles to Tissues
Current Gene Therapy Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication
Current Pharmaceutical Design Multiple Myeloma and the Immune Microenvironment
Current Cancer Drug Targets DNA Polymerases and Oxidative Damage: Friends or Foes?
Current Molecular Pharmacology Anti-Cancer Agent-Induced Nephrotoxicity
Anti-Cancer Agents in Medicinal Chemistry The Influenza Virus NS1 Protein: Inhibitor of Innate and Adaptive Immunity
Infectious Disorders - Drug Targets Antitumoral Activity of Interferon-γ Involved in Impaired Immune Function in Cancer Patients
Current Drug Metabolism Copper-62 Labeled ReCCMSH Peptide Analogs for Melanoma PET Imaging
Current Radiopharmaceuticals Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview
Mini-Reviews in Medicinal Chemistry Bioresorbable and Nonresorbable Polymers for Bone Tissue Engineering Jordi Girones
Current Pharmaceutical Design Metabolic Features of Melanoma: A Gold Mine of New Therapeutic Targets?
Current Cancer Drug Targets Advances in DNA-Ligands with Groove Binding, Intercalating and/or Alkylating Activity: Chemistry, DNA-Binding and Biology
Current Medicinal Chemistry NMR-based Metabolite Profiling of Pancreatic Cancer
Current Metabolomics